These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 28317415)

  • 1. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.
    Hohnloser SH; Calkins H; Willems S; Verma A; Schilling R; Okumura K; Nordaby M; Kleine E; Biss B; Gerstenfeld EP;
    J Interv Card Electrophysiol; 2019 Aug; 55(2):145-152. PubMed ID: 30758702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
    Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
    JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Michaud GF; Taveras J; Alviz I; Grupposo V; Cerna L; Avendano R; Kumar S; Kirchhof P; Natale A; Di Biase L
    Europace; 2018 Oct; 20(10):1612-1620. PubMed ID: 29982383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
    Xing Y; Xu B; Xu C; Peng F; Yang B; Qiu Y; Sun Y; Wang S; Guo H
    Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.
    Zhang RF; Ma CM; Wang N; Yang MH; Li WW; Yin XM; Dong YX; Yu XH; Xiao XJ; Xia YL; Gao LJ
    BMC Cardiovasc Disord; 2021 Apr; 21(1):214. PubMed ID: 33906609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Intern Med; 2015; 54(10):1167-73. PubMed ID: 25986252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
    Bassiouny M; Saliba W; Rickard J; Shao M; Sey A; Diab M; Martin DO; Hussein A; Khoury M; Abi-Saleh B; Alam S; Sengupta J; Borek PP; Baranowski B; Niebauer M; Callahan T; Varma N; Chung M; Tchou PJ; Kanj M; Dresing T; Lindsay BD; Wazni O
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):460-6. PubMed ID: 23553523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
    Calkins H; Willems S; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Kleine E; Bis B; Gerstenfeld EP
    Europace; 2019 Jun; 21(6):879-885. PubMed ID: 30982849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
    J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
    Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K
    J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of uninterrupted low-intensity warfarin for cryoballoon ablation of atrial fibrillation in the elderly: A pilot study.
    Xing Y; Xu B; Sheng X; Xu C; Peng F; Sun Y; Wang S; Guo H
    J Clin Pharm Ther; 2018 Jun; 43(3):401-407. PubMed ID: 29484682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.
    De Heide J; Vroegh CJ; Bhagwandien RE; Wijchers SA; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
    J Interv Card Electrophysiol; 2018 Dec; 53(3):341-346. PubMed ID: 30074120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.